United Statesthenext.jnjmedtech.com
Johnson & Johnson MedTech is the medical technology business of Johnson & Johnson. It designs, manufactures, and services medical devices and digital tools used in surgical, orthopedic, cardiovascular, ophthalmic, and neurovascular care. Its portfolio includes well-known franchises such as Ethicon (surgical technologies), DePuy Synthes (orthopedics), Biosense Webster (cardiac electrophysiology), CERENOVUS (neurovascular), Mentor (aesthetic and reconstructive), Johnson & Johnson Vision (eye health), and Abiomed (heart recovery).
The company’s offerings span wound closure, endoscopic instruments, joint reconstruction and trauma, electrophysiology mapping and ablation, stroke intervention, ophthalmic devices, and support for minimally invasive and robotic-assisted procedures. Johnson & Johnson MedTech operates globally with R&D, manufacturing, and clinical support functions aligned to regulatory and quality standards for healthcare products.
Randomized MEMBRANE trial found adding middle meningeal artery embolization with TRUFILL n‑BCA to standard care lowered chronic subdural hematoma recurrence and re‑intervention.
12‑month post‑market study: 84.2% freedom from atrial arrhythmia (90.5% paroxysmal; 75.3% persistent); 0.8% primary adverse events; CE‑mark allows ablation beyond pulmonary veins
The registry will gather real-world data on PFA for AFib, aiming to improve treatment strategies and outcomes in electrophysiology.
FDA approves TRUFILL n-BCA for MMA embolization in chronic subdural hematoma, offering a minimally invasive alternative to surgery with proven safety and effectiveness.
DISRUPT BTK II study shows IVL's effectiveness in treating calcified lesions, reducing amputations, and improving quality of life for PAD patients.
The Polyphonic AI Fund supports AI-driven surgical innovations, awarding Mayo Clinic and QAS.AI for projects enhancing surgical precision and decision-making.
